AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gluwin M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Ambrosia Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gluwin M 1mg/500mg Tablet SR

Diabetace M, a 1mg/500mg extended-release tablet, is an antidiabetic medication combining two agents for adult type 2 diabetes management. It regulates blood glucose. Diabetace M should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabetace M is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.

Primary Ingredients of Gluwin M 1mg/500mg Tablet SR

The provided text is "undefined," offering no content to rephrase.

Uses of Gluwin M 1mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Gluwin M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Gluwin M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

Common Side effects of Gluwin M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gluwin M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Gluwin M 1mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Gluwin M 1mg/500mg Tablet SR works:

Gluwin M SR tablets (1mg/500mg) contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Gluwin M 1mg/500mg Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Gluwin M (1mg/500mg) tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Gluwin M (1mg/500mg) tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gluwin M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Gluwin M 1mg/500mg SR tablet use. Physician consultation is essential. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gluwin M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, Gluwin M 1mg/500mg Tablet SR should generally begin at a low dose; it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gluwin M 1mg/500mg Tablet SR :

Should you forget a Gluwin M 1mg/500mg Tablet SR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gluwin M 1mg/500mg Tablet SR

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Gluwin M 1mg/500mg Tablet SR

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Gluwin M 1mg/500mg Tablet SR use may result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly concerning for individuals with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can include muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms arise, discontinue Gluwin M 1mg/500mg Tablet SR and seek immediate medical attention.
Gluwin M 1mg/500mg Extended-Release Tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when coupled with a balanced diet and regular physical activity. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for treating type 1 diabetes mellitus.
Gluwin M 1mg/500mg Tablet SR may cause frequent side effects including low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, and headache. Rare but potentially serious adverse reactions such as lactic acidosis may also occur. Prolonged administration might result in Vitamin B12 deficiency.
Prolonged administration of Gluwin M 1mg/500mg Tablet SR can indeed lead to Vitamin B12 deficiency. This medication impedes the gastrointestinal absorption of Vitamin B12. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. Preventive strategies proposed by some investigators include annual supplemental Vitamin B12 intake.
Indeed, Gluwin M 1mg/500mg SR tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Gluwin M 1mg/500mg SR tablets and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Gluwin M 1mg/500mg Tablet...
34
MRP 42
19% off